GSK602
|
|
- CAS号:
- 1714146-59-4
- 英文名:
- I-BRD9
- 英文别名:
- I-BRD9;GSK602;CS-2328;I-BRD9;I-BRD-9;I-brd9 GSK602;N-(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)-5-ethyl-4-oxo-7-(3-(trifluoromethyl)phenyl)-4,5-di;N-(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)-5-ethyl-4-oxo-7-(3-(trifluoromethyl)phenyl)-4,5-dihydrothieno[3,2-c]pyridine-2-carboximidamide;5-Ethyl-4,5-dihydro-4-oxo-N-(tetrahydro-1,1-dioxido-2H-thiopyran-4-yl)-7-[3-(trifluoromethyl)phenyl]thieno[3,2-c]pyridine-2-carboximidamide;Thieno[3,2-c]pyridine-2-carboximidamide, 5-ethyl-4,5-dihydro-4-oxo-N-(tetrahydro-1,1-dioxido-2H-thiopyran-4-yl)-7-[3-(trifluoromethyl)phenyl]-
- 中文名:
- GSK602
- 中文别名:
- 优选]I-BRD9;I-BRD9,BRD9抑制剂;N-(1,1-二氧化四氢-2H-噻喃-4-基)-5-乙基-4-氧代-7-(3-(三氟甲基)苯基)-4,5-二氢噻吩并[3,2-C]吡啶-2-甲脒;5-乙基-4,5-二氢-4-氧代-N-(四氢-1,1-二氧代-2H-噻喃-4-基)-7-[3-(三氟甲基)苯基]噻吩并[3,2-C]吡啶-2-甲脒
- CBNumber:
- CB83122929
- 分子式:
- C22H22F3N3O3S2
- 分子量:
- 497.55
- MOL File:
- 1714146-59-4.mol
|
|
|
GSK602化学性质
-
沸点:
-
683.9±65.0 °C(Predicted)
-
|
-
密度:
-
1.50±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
Soluble in DMSO
-
|
-
形态:
-
crystalline solid
-
|
-
酸度系数(pKa):
-
9.35±0.40(Predicted)
-
|
GSK602性质、用途与生产工艺
I-BRD9 (GSK602)可用作一种有效的、选择性BRD9抑制剂,其pIC50为7.3。针对BRD4,其pIC50为5.3。
I-BRD9是通过结构药物设计方法鉴定出来的,其选择性比对BET家族高700多倍以上,比对高度同源的BRD7高200倍以上。I-BRD9在 Kasumi-1细胞中被用来鉴定受BRD9调控、参与肿瘤、免疫反应途径的相关基因。
GSK602
上下游产品信息
上游原料
下游产品
更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
---|
2024/01/25 | HY-18975 | I-BRD9 | | 1 mg | 312元 |
2024/01/25 | HY-18975 | GSK602 I-BRD9 | 1714146-59-4 | 5mg | 780元 |
1714146-59-4, GSK602 相关搜索:
- API
- 合成有机化合物配体
- 活性小分子库
- 抑制剂
- C22H22F3N3O3S2
- I-BRD9,BRD9抑制剂
- 优选]I-BRD9
- N-(1,1-二氧化四氢-2H-噻喃-4-基)-5-乙基-4-氧代-7-(3-(三氟甲基)苯基)-4,5-二氢噻吩并[3,2-C]吡啶-2-甲脒
- 5-乙基-4,5-二氢-4-氧代-N-(四氢-1,1-二氧代-2H-噻喃-4-基)-7-[3-(三氟甲基)苯基]噻吩并[3,2-C]吡啶-2-甲脒
- 1714146-59-4
- N-(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)-5-ethyl-4-oxo-7-(3-(trifluoromethyl)phenyl)-4,5-dihydrothieno[3,2-c]pyridine-2-carboximidamide
- Thieno[3,2-c]pyridine-2-carboximidamide, 5-ethyl-4,5-dihydro-4-oxo-N-(tetrahydro-1,1-dioxido-2H-thiopyran-4-yl)-7-[3-(trifluoromethyl)phenyl]-
- CS-2328
- I-BRD9;I-BRD-9
- 5-Ethyl-4,5-dihydro-4-oxo-N-(tetrahydro-1,1-dioxido-2H-thiopyran-4-yl)-7-[3-(trifluoromethyl)phenyl]thieno[3,2-c]pyridine-2-carboximidamide
- N-(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)-5-ethyl-4-oxo-7-(3-(trifluoromethyl)phenyl)-4,5-di
- GSK602
- I-brd9 GSK602
- I-BRD9